Gracey Craig 的 Form 4/A 修正申報
修正Omada Health, Inc.（OMDA），2026/7/8 申報
- 申報編號
- 0001610717-26-000333
- 申報時間
- 2026/7/8 20:20 ET
- 交易日
- 2026/6/24
- 申報延遲
- 14 天
- 10b5-1 計畫
- 有勾選
- 原始申報日
- 2026/6/26
這份申報列了 2 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $3.96 萬。交易後 14 天申報。
這份修正申報取代了 0001610717-26-000298（2026/6/26 申報）。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Gracey CraigCIK 0002021724 | 高階主管（會計主管） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/6/24 | Common Stock | M行使選擇權取得 | +2,083 | $6.57 | +$13,685.31 | 17,524 | 直接 | |
| 2026/6/24 | Common Stock | S賣出處分 | −2,083 | $19.01F3 | −$39,601.58 | 15,441 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/6/24 | Common Stock | M行使選擇權處分 | −2,083 | $0.00 | $0 | 39,584 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
This Form 4/A restates in its entirety the original Form 4 filed on 6/26/2026 to report exercise transaction that was inadvertently omitted from the original filing. The exercise reported herein was part of a same-day exercise-and-sale transaction, and the corresponding sale was timely reported in the original Form 4. Due to the omission of this exercise transaction, the amount of securities beneficially owned following the sale was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.
- F2
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
- F3
This transaction was executed in multiple trades at prices ranging from $19.00 to $19.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F4
25% of the shares subject to the option vested on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.